| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4420508
[patent_doc_number] => 06194577
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-27
[patent_title] => 'Process for producing alicyclic hydrazine derivatives, tetra-hydropyridazine and hexahydropyridazine'
[patent_app_type] => 1
[patent_app_number] => 9/337607
[patent_app_country] => US
[patent_app_date] => 1999-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14569
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/194/06194577.pdf
[firstpage_image] =>[orig_patent_app_number] => 337607
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/337607 | Process for producing alicyclic hydrazine derivatives, tetra-hydropyridazine and hexahydropyridazine | Jun 20, 1999 | Issued |
| 09/337408 | POLYCYCLIC A-AMINO-E-CAPROLACTAMS AND RELATED COMPOUNDS | Jun 20, 1999 | Abandoned |
Array
(
[id] => 1565475
[patent_doc_number] => 06339091
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-15
[patent_title] => 'Comptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues'
[patent_app_type] => B1
[patent_app_number] => 09/332520
[patent_app_country] => US
[patent_app_date] => 1999-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50422
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 925
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/339/06339091.pdf
[firstpage_image] =>[orig_patent_app_number] => 09332520
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/332520 | Comptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues | Jun 13, 1999 | Issued |
| 09/332318 | 1-AZATRICYCLIC-4-BENZYLPIPERAZINES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS | Jun 13, 1999 | Abandoned |
Array
(
[id] => 4294776
[patent_doc_number] => 06180644
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-30
[patent_title] => 'Immunotherapeutic agents'
[patent_app_type] => 1
[patent_app_number] => 9/330701
[patent_app_country] => US
[patent_app_date] => 1999-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13014
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/180/06180644.pdf
[firstpage_image] =>[orig_patent_app_number] => 330701
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/330701 | Immunotherapeutic agents | Jun 10, 1999 | Issued |
Array
(
[id] => 4192509
[patent_doc_number] => 06130212
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-10
[patent_title] => 'Use of novel organoselenium compounds as pro-oxidizing agents, their methods of preparation and pharmaceutical compositions and application thereof'
[patent_app_type] => 1
[patent_app_number] => 9/329755
[patent_app_country] => US
[patent_app_date] => 1999-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16794
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1984
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/130/06130212.pdf
[firstpage_image] =>[orig_patent_app_number] => 329755
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/329755 | Use of novel organoselenium compounds as pro-oxidizing agents, their methods of preparation and pharmaceutical compositions and application thereof | Jun 9, 1999 | Issued |
Array
(
[id] => 4331131
[patent_doc_number] => 06313135
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-06
[patent_title] => 'Analogues of camptothecin, preparation procedures, their application as medicines and the pharmaceutical compositions comprising them'
[patent_app_type] => 1
[patent_app_number] => 9/325913
[patent_app_country] => US
[patent_app_date] => 1999-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24963
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1082
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/313/06313135.pdf
[firstpage_image] =>[orig_patent_app_number] => 325913
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/325913 | Analogues of camptothecin, preparation procedures, their application as medicines and the pharmaceutical compositions comprising them | Jun 3, 1999 | Issued |
Array
(
[id] => 1462807
[patent_doc_number] => 06350741
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-02-26
[patent_title] => 'Inhibitors of interleukin-1 converting enzyme'
[patent_app_type] => B1
[patent_app_number] => 09/326494
[patent_app_country] => US
[patent_app_date] => 1999-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17933
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/350/06350741.pdf
[firstpage_image] =>[orig_patent_app_number] => 09326494
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/326494 | Inhibitors of interleukin-1 converting enzyme | Jun 3, 1999 | Issued |
Array
(
[id] => 4326591
[patent_doc_number] => 06329365
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-11
[patent_title] => 'Inhibitors of interleukin-1.beta. converting enzyme'
[patent_app_type] => 1
[patent_app_number] => 9/326495
[patent_app_country] => US
[patent_app_date] => 1999-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16950
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/329/06329365.pdf
[firstpage_image] =>[orig_patent_app_number] => 326495
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/326495 | Inhibitors of interleukin-1.beta. converting enzyme | Jun 3, 1999 | Issued |
Array
(
[id] => 4304177
[patent_doc_number] => 06251885
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-26
[patent_title] => 'Cytotrienins, process for preparing the same and anti-tumor agent'
[patent_app_type] => 1
[patent_app_number] => 9/322982
[patent_app_country] => US
[patent_app_date] => 1999-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 3892
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/251/06251885.pdf
[firstpage_image] =>[orig_patent_app_number] => 322982
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/322982 | Cytotrienins, process for preparing the same and anti-tumor agent | May 31, 1999 | Issued |
Array
(
[id] => 4118570
[patent_doc_number] => 06071903
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-06-06
[patent_title] => '2,3,4,5-tetrahydro-1H-[1,4]-benzodiazepine-3-hydroxyamic acids'
[patent_app_type] => 1
[patent_app_number] => 9/318919
[patent_app_country] => US
[patent_app_date] => 1999-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37496
[patent_no_of_claims] => 85
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 635
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/071/06071903.pdf
[firstpage_image] =>[orig_patent_app_number] => 318919
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/318919 | 2,3,4,5-tetrahydro-1H-[1,4]-benzodiazepine-3-hydroxyamic acids | May 25, 1999 | Issued |
Array
(
[id] => 4330805
[patent_doc_number] => 06320045
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-20
[patent_title] => 'Process for the reduction of oxiranyl epothilones to olefinic epothilones'
[patent_app_type] => 1
[patent_app_number] => 9/316796
[patent_app_country] => US
[patent_app_date] => 1999-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3870
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 332
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/320/06320045.pdf
[firstpage_image] =>[orig_patent_app_number] => 316796
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/316796 | Process for the reduction of oxiranyl epothilones to olefinic epothilones | May 20, 1999 | Issued |
| 09/308311 | Heterocyclic compounds, their production and use as tachykinin receptor antagonists | May 17, 1999 | Abandoned |
Array
(
[id] => 4260968
[patent_doc_number] => 06258805
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-10
[patent_title] => 'Pyrroloazepine derivatives'
[patent_app_type] => 1
[patent_app_number] => 9/312713
[patent_app_country] => US
[patent_app_date] => 1999-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38363
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 893
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/258/06258805.pdf
[firstpage_image] =>[orig_patent_app_number] => 312713
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/312713 | Pyrroloazepine derivatives | May 16, 1999 | Issued |
Array
(
[id] => 4423448
[patent_doc_number] => 06225465
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-01
[patent_title] => 'Process for the aminocarbonylation of benzazepines and benzodiazepines'
[patent_app_type] => 1
[patent_app_number] => 9/091966
[patent_app_country] => US
[patent_app_date] => 1999-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9155
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/225/06225465.pdf
[firstpage_image] =>[orig_patent_app_number] => 091966
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/091966 | Process for the aminocarbonylation of benzazepines and benzodiazepines | May 13, 1999 | Issued |
Array
(
[id] => 4187391
[patent_doc_number] => 06093721
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-25
[patent_title] => 'Amidino-camptothecin derivatives'
[patent_app_type] => 1
[patent_app_number] => 9/269177
[patent_app_country] => US
[patent_app_date] => 1999-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2510
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/093/06093721.pdf
[firstpage_image] =>[orig_patent_app_number] => 269177
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/269177 | Amidino-camptothecin derivatives | May 12, 1999 | Issued |
Array
(
[id] => 4298459
[patent_doc_number] => 06197958
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-06
[patent_title] => 'Carboxylic acid derivatives, their preparation and use'
[patent_app_type] => 1
[patent_app_number] => 9/309770
[patent_app_country] => US
[patent_app_date] => 1999-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14344
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 679
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/197/06197958.pdf
[firstpage_image] =>[orig_patent_app_number] => 309770
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/309770 | Carboxylic acid derivatives, their preparation and use | May 10, 1999 | Issued |
Array
(
[id] => 4106001
[patent_doc_number] => 06051706
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-18
[patent_title] => 'Method of producing .epsilon.-caprolactam'
[patent_app_type] => 1
[patent_app_number] => 9/309506
[patent_app_country] => US
[patent_app_date] => 1999-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1311
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/051/06051706.pdf
[firstpage_image] =>[orig_patent_app_number] => 309506
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/309506 | Method of producing .epsilon.-caprolactam | May 10, 1999 | Issued |
Array
(
[id] => 951375
[patent_doc_number] => 06960579
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-11-01
[patent_title] => 'Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders'
[patent_app_type] => utility
[patent_app_number] => 09/674403
[patent_app_country] => US
[patent_app_date] => 1999-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6333
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/960/06960579.pdf
[firstpage_image] =>[orig_patent_app_number] => 09674403
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/674403 | Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders | May 9, 1999 | Issued |
Array
(
[id] => 4295896
[patent_doc_number] => 06184216
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-06
[patent_title] => 'Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus'
[patent_app_type] => 1
[patent_app_number] => 9/307135
[patent_app_country] => US
[patent_app_date] => 1999-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5814
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/184/06184216.pdf
[firstpage_image] =>[orig_patent_app_number] => 307135
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/307135 | Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus | May 6, 1999 | Issued |
